Adalimumab Biosimilar-to-biosimilar Switch in Patients with Inflammatory Rheumatic Diseases – Real-world Evidence from the Nationwide Danish Registry, DANBIO

Background/Purpose: In Denmark, mandatory switches between originators and corresponding biosimilar products have been performed for economic reasons for nearly a decade (1). Starting in January 2021, a biosimilar-to-biosimilar adalimumab switch from SB5 (Imraldi®) to GP2017 (Hyrimoz®) was performed in patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA). A subgroup of patients […]

Authors

Institutions

Publication Details

Journal
VBN Forskningsportal (Aalborg Universitet)
Published
2024-10-11
Primary Topic
Biosimilars and Bioanalytical Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Adalimumab Biosimilar-to-biosimilar Switch in Patients with Inflammatory Rheumatic Diseases – Real-world Evidence from the Nationwide Danish Registry, DANBIO

Natalia Manilo, Hafsah Nabi, Niels Lomborg, René Østgård et al.
VBN Forskningsportal (Aalborg Universitet)
Biosimilars and Bioanalytical Methods
article

Adalimumab Biosimilar-to-biosimilar Switch in Patients with Inflammatory Rheumatic Diseases – Real-world Evidence from the Nationwide Danish Registry, DANBIO

Natalia Manilo, Hafsah Nabi, Niels Lomborg, René Østgård, Søren Andreas Just, Kamilla Danebod, Pia Høger Thygesen, Salome Kristensen, Anne Gitte Loft, Asta Linauskas, Oliver Hendricks, Jens Z. Pedersen, Stavros Chrysidis, Ada Colic, Merete Lund Hetland, Heidi Lausten Munk, Kasper Yde Jensen, Dorte Vendelbo Jensen, Bente Glintborg, Malene Kildemand, Pil Højgaard
article en

Abstract

Background/Purpose: In Denmark, mandatory switches between originators and corresponding biosimilar products have been performed for economic reasons for nearly a decade (1). Starting in January 2021, a biosimilar-to-biosimilar adalimumab switch from SB5 (Imraldi®) to GP2017 (Hyrimoz®) was performed in patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA). A subgroup of patients […]

VBN Forskningsportal (Aalborg Universitet)
University of Copenhagen (DK), University of Southern Denmark (DK), Aarhus University (DK), Aalborg University Hospital (DK), Odense University Hospital (DK), Aarhus University Hospital (DK), Copenhagen University Hospital (DK), Rigshospitalet (DK), Zealand University Hospital (DK), Regionshospital Nordjylland (DK), Region of Southern Denmark (DK), Helse Førde (NO), Danish Institute of Fire and Security Technology (DK), Regional Hospital Central Jutland (DK), Aalborg University (DK)
Openalex Percentile: Top 68%
Biosimilars and Bioanalytical Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.